Karo Healthcare has hired Bayer’s Michael Kaltenborn as its chief strategy & corporate development officer, effective from 1 February.
Kaltenborn replaces Carl Lindgren who is leaving the Swedish company to pursue private
People On The Move: Appointments At Karo, Haleon, Holland & Barrett
A round-up of the latest appointments in Europe's health and wellness market: Sweden's Karo hires CSDO from Bayer; Haleon promotes Limnidis to lead DACH; and Holland & Barrett hires ex-WBA exec Alex Gourlay.
More from Europe
• By
At a recent plenary session the European Parliament adopted a resolution calling on the European Commission to “conduct a new and comprehensive assessment” of the impact of the revised Urban Wastewater Treatment Directive on the pharmaceutical sector.
• By
Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”
• By
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
• By
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
More from Geography
• By
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
• By
An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.
• By
HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.